Food and Drug Administration Drug Safety Podcast
FDA Drug Safety Podcast: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:03:00
- More information
Informações:
Synopsis
Listen to an audio podcast of the December 19, 2017 FDA Drug Safety Communication "FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings". This is an update to the FDA Drug Safety Communication: FDA identifies no harmful effects to date with br
